RxDoctor Payments Data

Lauren Murphy

Nurse Practitioner · Mooresville, NCNPI 1396412532

Payments from drug & device makers

$5,735in general payments, 2019–2025

Across 312 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$899
  • AbbVie$858
  • Collegium Pharmaceutical, Inc.$489
  • Forte Bio-pharma LLC$457
  • Boston Scientific$320
  • Novo Nordisk$211
  • plus $3K from 40 others

What the payments were for

  • Food & beverage$5,68999%
  • Education$461%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,735 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina

Medicare billing

Part B allowed, 2024
$33,161
Medicare patients
187
Services billed
489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban23$30,021
OzempicSemaglutide17$19,537
ZtlidoLidocaine26$13,080
Xtampza ErOxycodone Myristate20$11,238
MovantikNaloxegol Oxalate14$5,586
Buprenorphine21$5,020
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen140$3,861
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen78$2,786
Naloxone Hcl20$1,512
Celecoxib75$1,504
Diclofenac Sodium17$1,461
Gabapentin103$1,423
Oxycodone Hcl65$1,173
Pregabalin58$1,118
Atorvastatin Calcium87$1,003

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$156$30,02123 claims
Novo NordiskOzempic$211$19,53717 claims
Scilex Pharmaceuticals Inc.Ztlido$127$13,08026 claims
Collegium Pharmaceutical, Inc.Xtampza Er$489$11,23820 claims
Redhill Biopharma Inc.Movantik$119$5,58614 claims
Hikma Pharmaceuticals USABuprenorphine$203$5,02021 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Mooresville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →